Updated for the 2026-2027 CFA® Level I curriculum.
Patents, acquired customer relationships, and qualifying software can appear as intangible assets on a company's balance sheet. CFA Level I tests whether you understand when a company can put an intangible asset on the books, how it measures that asset, and what it must disclose afterward. The IFRS and US GAAP treatment of internally developed intangibles is an important curriculum comparison.
Quick Answer
Intangible assets on the balance sheet are identifiable, non-physical assets recognized only when future economic benefits are probable and cost can be measured reliably. Purchased or acquired intangibles are capitalized at cost or fair value. Internally generated research costs are expensed immediately, while development costs may be capitalized under IFRS if strict criteria are met. US GAAP generally expenses both. Finite-life intangibles are amortized; indefinite-life intangibles are tested annually for impairment instead.
Key Takeaways
An intangible asset is identifiable, non-monetary, and lacks physical substance.
Recognition requires two conditions: probable future economic benefit and reliable cost measurement.
Purchased and acquired intangibles are capitalized at cost or acquisition-date fair value.
Internally generated research costs are always expensed as incurred.
IFRS permits capitalizing development costs once six specific criteria are met; US GAAP generally expenses development costs too, with narrow exceptions.
Finite-life intangibles are amortized over useful life; indefinite-life intangibles are not amortized but tested for impairment at least annually.
Disclosures include useful lives, amortization method, gross carrying amount, and accumulated amortization or impairment.
What You Need to Know for CFA Level I
The LOS asks you to explain, so expect conceptual questions on recognition and disclosure, not just memorized rules.
Know the two-part recognition test: probable benefit and reliable measurement.
Be ready to compare IFRS and US GAAP treatment of development costs. This is a classic exam distinction.
Keep a clear boundary with goodwill. Goodwill is not an identifiable intangible asset and is not amortized under either framework. That treatment lives in a separate note.
The most common trap is treating all R&D spending the same way. Research and development are treated differently, and the IFRS/GAAP gap makes this testable.
What Qualifies as an Intangible Asset?
An intangible asset is a non-monetary asset without physical substance that a company controls and expects to generate future economic benefits. Both IFRS and US GAAP require the asset to be identifiable, meaning it is either separable (can be sold, licensed, or transferred on its own) or arises from contractual or legal rights.
Two conditions must both hold before a company can recognize an intangible asset:
It is probable that future economic benefits will flow to the company.
The cost of the asset can be measured reliably.
Internally generated brands generally cannot be recognized, and an assembled workforce generally fails separate recognition requirements. An identifiable acquired brand can be recognized, so distinguish internal value from purchased or acquired assets.
How Are Purchased and Acquired Intangibles Recognized?
When a company buys an intangible asset directly, such as a patent or a trademark, it records the asset at cost, which includes the purchase price plus any costs needed to prepare the asset for use.
When intangible assets come from a business combination (one company acquiring another), the acquirer records each identifiable intangible asset separately at fair value on the acquisition date. This is different from goodwill, which absorbs the residual amount that cannot be assigned to any identifiable asset. If an acquired intangible cannot be separately identified and measured, it becomes part of goodwill instead.
How Are Internally Generated Intangibles Treated?
This is where IFRS and US GAAP diverge, and it is a frequent exam point.
Internally generated intangibles usually come from a research and development process, which accounting standards split into two phases:
Phase | Definition | IFRS Treatment | US GAAP Treatment |
|---|---|---|---|
Research | Investigation aimed at gaining new knowledge | Expensed as incurred | Expensed as incurred |
Development | Application of research findings to a plan before commercial production | Capitalized if six criteria are met | Expensed as incurred (with narrow exceptions, such as certain software costs) |
Under IFRS, a company can capitalize development costs only after it can demonstrate all of the following:
Technical feasibility of completing the asset
Intention to complete and use or sell the asset
Ability to use or sell the asset
How the asset will generate probable future economic benefits
Availability of resources to complete development
Ability to reliably measure the development expenditure
US GAAP takes a more conservative approach. Most research and development costs are expensed as incurred, regardless of how far along the project is. This means two companies with identical development spending can report different balance sheets and income statements depending on which framework they use. For analysis, this difference affects asset values, net income timing, and comparability across companies.
How Are Intangible Assets Measured After Initial Recognition?
Once recognized, an intangible asset is classified by useful life, and that classification drives how it is measured going forward.
Finite-life intangibles (for example, a patent with a 15-year legal term) are amortized over their useful life, similar to depreciation on tangible assets. The amortization expense reduces net income and the carrying value of the asset each period.
Indefinite-life intangibles (for example, a trademark that can be renewed indefinitely) are not amortized. Instead, they are tested for impairment at least annually, and more often if conditions suggest a decline in value. If the carrying amount exceeds recoverable value, the company records an impairment loss.
This distinction matters for ratio analysis. A company with mostly indefinite-life intangibles will show no amortization expense related to those assets, which can make margins look stronger until an impairment hits.
What Must Companies Disclose About Intangible Assets?
Disclosure requirements let analysts assess how much judgment went into the numbers. Required disclosures generally include:
Whether useful lives are finite or indefinite, and the basis for that determination
Amortization methods used for finite-life intangibles
Gross carrying amount and accumulated amortization for each major class of intangible asset
Amount of amortization expense recognized during the period
Any impairment losses recognized, and the circumstances that led to them
Research and development costs expensed during the period (useful for comparing IFRS and US GAAP reporters)
These disclosures usually sit in the notes to the financial statements, not on the face of the balance sheet, so you need to check footnotes when comparing companies.
Working Example
Nexfield Robotics is developing a new sensor technology. During the year, it incurs the following costs:
$2.0 million investigating alternative sensor materials (early-stage research)
$3.5 million building a working prototype after confirming technical feasibility, market demand, and funding availability
Step 1: Classify the costs.
The $2.0 million is research. Nexfield has not yet confirmed feasibility or a plan for commercial use. This amount is expensed under both IFRS and US GAAP.
Step 2: Apply the development cost test.
Assume Nexfield demonstrates all six development criteria before incurring the $3.5 million. The amount is directly attributable to development expenditure on technology that is not yet available for use.
Step 3: Apply the accounting treatment.
Framework | Research ($2.0 mm) | Development ($3.5 mm) |
|---|---|---|
IFRS | Expensed | Capitalized as an intangible asset |
US GAAP | Expensed | Expensed |
Under IFRS, Nexfield reports a $3.5 million intangible asset and a smaller expense hit to net income this year. Under US GAAP, Nexfield expenses the full $5.5 million, reducing net income more sharply but keeping the balance sheet smaller. An analyst comparing an IFRS reporter to a US GAAP reporter in the same industry needs to adjust for this difference before comparing margins or asset turnover.
Common Exam Traps
Treating all R&D spending the same way
Research is always expensed. Development costs can be capitalized under IFRS once specific criteria are met. Classify the expenditure before applying the recognition rule.
Confusing identifiable intangibles with goodwill
Goodwill arises only as a residual in a business combination and is never amortized. Identifiable intangibles acquired in that same deal are recorded separately at fair value and may be amortized if they have a finite life.
Assuming indefinite-life means permanent
Indefinite-life intangibles are not amortized, but they still face annual impairment testing. "Indefinite" describes useful life, not protection from write-downs.
Ignoring the disclosure footnotes
The balance sheet shows one net number for intangible assets. The breakdown between finite-life and indefinite-life assets, and the related amortization and impairment details, only appear in the notes.
Forgetting purchased intangibles get capitalized regardless of type
The research versus development distinction applies to internally generated intangibles. A purchased patent or trademark is capitalized at cost even if the seller originally treated the underlying development as research.
Practice Question
Hallridge Pharma incurs $4 million studying a new compound's chemical properties with no confirmed commercial application yet. In the same year, it spends $6 million directly attributable development work on a different compound after demonstrating all six IAS 38 criteria. The expenditure excludes separately identifiable equipment, and the intangible asset is not yet available for use. Hallridge reports under IFRS. How should Hallridge treat these costs?
Expense both the $4 million and the $6 million as incurred.
Expense the $4 million and capitalize the $6 million as an intangible asset.
Capitalize both amounts as intangible assets.
Correct Answer: B
Explanation: The $4 million is research because Hallridge has not confirmed a commercial application. IFRS requires research costs to be expensed. The question establishes that all six development recognition criteria are met. IFRS allows capitalization once these criteria are met.
Option A: Incorrect. This ignores that the $6 million meets the IFRS development capitalization criteria.
Option C: Incorrect. Research costs cannot be capitalized under IFRS regardless of later success.
Continue Your CFA Level I Prep With KeyPoint
Use structured lessons, practice questions, mock exams, and progress tracking to focus on the time you have left
FAQs About Intangible Assets: Reporting and Disclosures
How should intangible assets be disclosed on the balance sheet?
Companies report a net intangible assets figure on the balance sheet, then break it down in the notes by useful life classification, amortization method, gross carrying amount, accumulated amortization, and any impairment losses recognized during the period.
Are all intangible assets amortized?
No. Only finite-life intangible assets are amortized. Indefinite-life intangibles are not amortized but are tested for impairment at least once a year.
Why do IFRS and US GAAP treat development costs differently?
IFRS allows capitalization once a company proves technical feasibility, intent, resources, and reliable measurement. US GAAP takes a more conservative view and generally expenses development costs as incurred, with narrow exceptions. This creates a comparability gap between reporters using each framework.
Is goodwill an intangible asset?
Goodwill lacks physical substance but is not considered an identifiable intangible asset. It arises only in business combinations as a residual amount and follows its own impairment-only treatment, covered in a separate study note.
Can a company capitalize the cost of building its own brand?
No. Internally generated brands, customer lists, and similar items fail the reliable measurement test and are never recognized as intangible assets, even though the company may spend heavily to build them.